| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 05/14/2009 | US20090123464 Method for the potentiation of opioid analgesics effects on pain |
| 05/14/2009 | US20090123459 Compositions and method for the diagnosis, prevention and treatment of alzheimer's disease |
| 05/14/2009 | US20090123452 Protease screening methods and proteases identified thereby |
| 05/14/2009 | US20090123433 Compositions Comprising Human Embryonic Stem Cells and their Derivatives, Methods of Use, and Methods of Preparation |
| 05/14/2009 | DE10163130B4 Apoptotisch wirksame Peptide und diese umfassende pharmazeutische Zusammensetzungen Apoptotic active peptides and pharmaceutical compositions comprising |
| 05/14/2009 | CA2742839A1 Novel neurturin conjugates for pharmaceutical use |
| 05/14/2009 | CA2705303A1 Modulation of protein trafficking |
| 05/14/2009 | CA2704981A1 Aldh-2 inhibitors in the treatment of psychiatric disorders |
| 05/14/2009 | CA2704803A1 7-azaindole derivatives as selective 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors |
| 05/14/2009 | CA2704473A1 4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases |
| 05/13/2009 | EP2058658A2 Method and means for influencing intercellular communication and intercellular organelle transport |
| 05/13/2009 | EP2058332A1 Use of CD25 binding molecules in steroid-resistant patients |
| 05/13/2009 | EP2058329A1 Improved secretion of neublastin |
| 05/13/2009 | EP2058317A1 Aminophosphoric acid ester derivative and s1p receptor modulator containing the same as active ingredient |
| 05/13/2009 | EP2058313A2 Process for synthesis and purification of anhydrous crystalline S-zopiclone |
| 05/13/2009 | EP2058310A1 Pyrazolopyridine carboxamide derivative and phosphodiesterase (pde) inhibitor comprising the derivative |
| 05/13/2009 | EP2058309A1 Fused heterocyclic compound |
| 05/13/2009 | EP2058306A1 Heteroaryl-substituted 2-pyridinyl-methylamine derivatives |
| 05/13/2009 | EP2058305A1 Urea derivative |
| 05/13/2009 | EP2058304A1 P2x4 receptor antagonist |
| 05/13/2009 | EP2058301A1 Pyrrolidine analogue for preventing neurogenic pain and method for production thereof |
| 05/13/2009 | EP2057997A1 Preventive and/or therapeutic agent for peripheral neuropathy |
| 05/13/2009 | EP2057162A2 Fused heterocyclic inhibitors of d-amino acid oxidase |
| 05/13/2009 | EP2057153A1 (3-aryl-piperazin-1-yl), (2-aryl-morpholin-4-yl) and (2-aryl- thiomorpholin-4-yl) derivatives of 6,7-dialkoxyquinazoline, 6,7- dialkoxyphtalazine and 6,7-dialkoxyisoquinoline |
| 05/13/2009 | EP2057138A1 Novel chromene and thiochromene carboxamide derivatives, methods for preparing same and therapeutic applications of same |
| 05/13/2009 | EP2057119A1 3- (ih-indol- 3-ydindan-1-ylamine derivatives for the treatment of depression and anxiety |
| 05/13/2009 | EP2056877A2 Pharmaceutical compositions of benzodiazepines and methods of use thereof |
| 05/13/2009 | EP2056876A1 Biomarkers for alzheimer's disease progression |
| 05/13/2009 | EP2056850A2 Therapeutic methods for neuropathic pain |
| 05/13/2009 | EP2056833A2 Derivatives of uric and thiouric acid for oxidative stress-related diseases |
| 05/13/2009 | EP2056825A2 Use of opioid formulations in needle-less drug delivery devices |
| 05/13/2009 | EP2056818A2 Compositions and methods for neuroprotection |
| 05/13/2009 | EP2056807A2 Treatment of inflammatory diseases |
| 05/13/2009 | EP2056806A2 Use of certain chemical compounds for the inhibition of the peptidyl-prolyl cis/trans isomerase activity of cyclophilins |
| 05/13/2009 | EP2056800A2 Therapy procedure for drug delivery for trigeminal pain |
| 05/13/2009 | EP1926723B1 Azabicyclo (3,1,0) hexan derivatives useful as modulators of dopamine d3 rceptors |
| 05/13/2009 | EP1721610B1 Composition containing benzamidine derivative and method for stabilizing benzamidine derivative |
| 05/13/2009 | EP1655028B1 Use of cyclic bioisosteres of purine system derivatives for the treatment of diseases caused by disorders of nitrergic and dopaminergic systems |
| 05/13/2009 | EP1581759B1 Methods for treating taxol-induced sensory neuropathy |
| 05/13/2009 | EP1549624B1 Inhibitors of fatty acid amide hydrolase |
| 05/13/2009 | EP1535616B1 Remedy for integration dysfunction syndrome |
| 05/13/2009 | EP1429770B1 New formulations and use thereof |
| 05/13/2009 | EP1397356B1 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (pai-1) |
| 05/13/2009 | EP1356812B1 Medicines for treatment and prevention of neurogenic pain |
| 05/13/2009 | EP1355646B1 Muscarinic receptor agonists |
| 05/13/2009 | EP1309692B1 Anti-il-12 antibodies, compositions, methods and uses |
| 05/13/2009 | EP1299104B1 Tamper-resistant oral opioid agonist formulations |
| 05/13/2009 | EP1261340B1 Compositions and methods for the treatment of parkinson's disease |
| 05/13/2009 | EP1115743B1 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use |
| 05/13/2009 | EP0934311B1 New heterocyclylmethyl-substituted pyrazol derivates |
| 05/13/2009 | CN101432286A Novel 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives and their medical use |
| 05/13/2009 | CN101432285A Pyrazolo-tetrahydro pyridine derivatives as orexin receptor antagonists |
| 05/13/2009 | CN101432283A N- (2-thiazolyl) -amide derivatives as GSK-3 inhibitors |
| 05/13/2009 | CN101432282A N- (2-thiazolyl) -amide derivatives as GSK-3 inhibitors |
| 05/13/2009 | CN101432280A Neurogenesis inducer or neuropathy therapeutic agent comprising alkyl ether derivative or salt thereof |
| 05/13/2009 | CN101432279A N-oxides of pyridylmethylpiperazine and -piperidine derivatives |
| 05/13/2009 | CN101432274A Sulfonyl-3-heterocyclylindazole derivatives as 5-hydroxytryptamine-6 ligands |
| 05/13/2009 | CN101432269A 1-sulfonylindazolylamine and -amide derivatives as 5-hydroxytryptamine-6 ligands |
| 05/13/2009 | CN101432014A Cathepsin propeptide and uses thereof |
| 05/13/2009 | CN101432008A Ginkgo biloba leaf extract having novel composition useful for prevention or treatment of alzheimer's disease and parkinson's disease, and extracting and purifying method thereof |
| 05/13/2009 | CN101431993A Use of DHA and ARA in the preparation of a composition for regulating gene expression |
| 05/13/2009 | CN101429497A In vitro cultivation method Olfactory stem cell |
| 05/13/2009 | CN101429217A Phospholipid type nervonic acid and method for producing the same |
| 05/13/2009 | CN101429185A Two-crystal type of substance of meletin, production method, medicament composition and uses thereof |
| 05/13/2009 | CN101429184A Two-crystal type of substance of luteolin, production method, medicament composition and uses thereof |
| 05/13/2009 | CN101429144A Crystalline form of (S)-2-phenylethylammonium (R)-diphenyl-methanesulphinyl-acetate |
| 05/13/2009 | CN101429134A New crystalline form VI of agomelatine, method of preparation and pharmaceutical compositions thereof |
| 05/13/2009 | CN101428138A Uses of Chilobrachys jingzhao toxin extract-jingzhao toxin-V in preparing pain easing medicament |
| 05/13/2009 | CN101428103A Formulation for treating senile dementia and Parkinsonismus |
| 05/13/2009 | CN101428099A Tea and capsule for relieving or neutralizing the effect of alcohol, and processing method thereof |
| 05/13/2009 | CN101428095A Medicinal liquor for treating semiplegia and preparation method thereof |
| 05/13/2009 | CN101428092A Uses of Chinese medicinal composition in preparing medicament for inhibiting leukocyte |
| 05/13/2009 | CN101428084A Health-care wine of orange and cassia |
| 05/13/2009 | CN101428080A Health care essential oil of magnolia flower |
| 05/13/2009 | CN101428068A Method for purifying ficus microcarpa leaf flavonoid compound with large-hole adsorption resin |
| 05/13/2009 | CN101428041A Cordyceps sinensis extract, preparation method and uses in preparing medicament |
| 05/13/2009 | CN101428021A Externally used medicament preparation for kicking craving for tobacco and wine |
| 05/13/2009 | CN100487124C Adeno-associated virus mediating trigenic cell expression system |
| 05/13/2009 | CN100486967C 5HT2C receptor modulators |
| 05/13/2009 | CN100486957C Process for producing amine derivatives |
| 05/13/2009 | CN100486621C Chinese medicinal composition for treating hemilateral headache and its preparation method |
| 05/13/2009 | CN100486597C A pharmaceutical composition made from Chinese traditional medicine for treating snuffle, headache and preparation method thereof |
| 05/13/2009 | CN100486576C Substituted pyridinones as modulators of P38MAP kinase |
| 05/13/2009 | CN100486574C Remedies and/or preventives for nervous system disorders |
| 05/13/2009 | CN100486573C Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and use |
| 05/13/2009 | CN100486571C Methods of treating benzodiazepine site (BZD-s) associated syndromes using 2' hydroxyflavonoids |
| 05/12/2009 | US7531670 Methods for treating cognitive/attention deficit disorders using tetrahydroindolone analogues and derivatives |
| 05/12/2009 | US7531625 Nucleotide sequences coding neuronal outgrowth and stability protein for use in treating ovarian, renal, neurological, cell proliferative and cardiovascular disorders |
| 05/12/2009 | US7531564 Substituted benzoxazoles as estrogenic agents |
| 05/12/2009 | US7531561 GSK-3 inhibitors |
| 05/12/2009 | US7531549 2-[(2-Isopropylsulfanyl-3-oxo-spiro[3.5]non-1-en-1-yl)amino]-3-[4-([2,7]naphthyridin-1-ylamino)phenyl]propanoic acid; compounds can inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders |
| 05/12/2009 | US7531545 2-amino-3,4-dihydro-pyrido[3,4-d]pyrimidine derivatives useful as inhibitors of β-secretase (BACE) |
| 05/12/2009 | US7531540 phosphodiesterase type 4 inhibitors; to treat respiratory disorders, skin disorders like psoriasis and atopic eczema; low toxicity, high bioavailability, no significant side effects; 2-{4-[(4aS,8aR)-4-(3,4-dimethoxyphenyl)-1-oxo-4a,5,8,8a-tetrahydro-1H-phthalazin-2-yl]-piperidin-1-yl}-acetamide |
| 05/12/2009 | US7531536 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 05/12/2009 | US7531532 Pyridine derivative and pyrimidine derivative |
| 05/12/2009 | US7531531 Method of treating diseases associated with altered kinase activity with bicyclo-pyrazoles |
| 05/12/2009 | US7531516 Antiinflammatory agents; multiple sclerosis; inflamamtory bowel disorders; antitumor agents; sepsis |
| 05/12/2009 | US7531183 Biologically active hemagglutinin from type A Clostridium botulinum and methods of use |
| 05/12/2009 | US7531175 Methods for modulation of immune responses using humanized immunoglobulins reactive with B7-1 molecules |
| 05/12/2009 | CA2475302C Controlled synthesis of ziprasidone and compositions thereof |